Finding hope for cancer patients in ferroptosis research
Guang Lei, M.D., Ph.D., spends his days in a lab studying ferroptosis, a type of programmed cell death.
But it’s not a love of science or a fascination with cells that brought him here, although he admits he has those, too. For Lei, it’s all about finding solutions for the struggling patients he met as a resident physician in China.
During his time as a student, Lei saw the struggles that cancer patients faced firsthand...
Gastrointestinal medical oncologist and researcher driven to help patients live longer
Van Morris, M.D., is driven to offer more to patients.
“I am reminded every day about the opportunities for improving treatments for...
Using multi-omics to advance ovarian cancer treatment
Every day on her way to her lab, Sammy Ferri-Borgogno, Ph.D., passed through the oncology waiting room. Seeing the faces, observing the interactions...
Pancreatic cancer survivor finds hope in cancer research
Helene Andrews-Polymenis finds hope in cancer research.
Like many cancer survivors, she often feels some anxiety when she thinks about the future. Her diagnosis, pancreatic ductal adenocarcinoma, is difficult to treat, and while Helene currently shows no evidence of disease, she worries about the possibility of another recurrence.
But she finds peace in the idea that right now scientists, physicians and other researchers...
5 ways MD Anderson is researching the link between food and cancer
The relationship between what we eat and drink and our cancer risk is complex. It’s been the subject of research for decades.
“Nutrition...
How four cancer researchers got their start and what motivates them
At MD Anderson, our care teams work hand in hand with scientists who bring the best treatments available today to our clinics while dreaming...
Meeting with a research nurse during a clinical trial: What to know
Enrolling in a clinical trial is one way to access cancer treatment that may not yet be broadly available while helping future cancer patients...